Variant report
Variant | nsv518324 |
---|---|
Chromosome Location | chr13:92917856-92955354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9589470 | chr13:92917856-92917857 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539794570 | chr13:92917868-92917869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138967765 | chr13:92917881-92917882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543981789 | chr13:92917898-92917899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113472853 | chr13:92917923-92917924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574202392 | chr13:92917948-92917949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541479963 | chr13:92917950-92917951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556375265 | chr13:92917990-92917991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140689730 | chr13:92918049-92918050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376778057 | chr13:92918068-92918069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144653301 | chr13:92918072-92918073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540669940 | chr13:92918139-92918140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564014742 | chr13:92918145-92918146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533108975 | chr13:92918205-92918206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550064260 | chr13:92918241-92918242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569723511 | chr13:92918264-92918265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs141132380 | chr13:92918272-92918273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186078712 | chr13:92918282-92918283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9523564 | chr13:92918347-92918348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs534996008 | chr13:92918361-92918362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558219251 | chr13:92918392-92918393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190946290 | chr13:92918409-92918410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150303678 | chr13:92918415-92918416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9589471 | chr13:92918429-92918430 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs555783813 | chr13:92918458-92918459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs61966572 | chr13:92918465-92918466 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs138063335 | chr13:92918482-92918483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542851927 | chr13:92918492-92918493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535593452 | chr13:92918517-92918518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs180943641 | chr13:92918527-92918528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368142801 | chr13:92918589-92918590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75899928 | chr13:92918623-92918624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9634481 | chr13:92918654-92918655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186166818 | chr13:92918672-92918673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143741796 | chr13:92918676-92918677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555450414 | chr13:92918752-92918753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7981189 | chr13:92918825-92918826 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs543305000 | chr13:92918862-92918863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77507761 | chr13:92918955-92918956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147230106 | chr13:92918979-92918980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549227761 | chr13:92918980-92918981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199698412 | chr13:92918986-92918987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189264189 | chr13:92922421-92922422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142785516 | chr13:92922458-92922459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528244214 | chr13:92922502-92922503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532130241 | chr13:92922503-92922504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72638616 | chr13:92922549-92922550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551913770 | chr13:92922645-92922646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182365630 | chr13:92922652-92922653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537720194 | chr13:92922676-92922677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92917200-92918200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr13:92917600-92919000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr13:92917600-92919000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:92918000-92919000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr13:92918800-92919000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr13:92922400-92922800 | Enhancers | Rectal Smooth Muscle | rectum |
7 | chr13:92933000-92933800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
8 | chr13:92933200-92933400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr13:92933200-92933800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
10 | chr13:92943400-92943600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr13:92943600-92950400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr13:92950400-92950600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr13:92950800-92951000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr13:92950800-92951000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr13:92950800-92951200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr13:92950800-92951600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr13:92951000-92951600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr13:92951000-92952600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr13:92951200-92952400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr13:92951600-92951800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr13:92952400-92952800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr13:92952400-92953800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr13:92953200-92953600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
24 | chr13:92954400-92956200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |